Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Torrent Pharma

    Tag: torrent pharma

    You Searched For "Torrent Pharma"
    Torrent Pharma says promoters havent pledged shares

    Torrent Pharma says promoters haven't pledged shares

    Medical Dialogues Bureau6 April 2020 11:45 AM IST
    New Delhi: Torrent Pharma has said that its promoters have not pledged any equity shares they hold in the company for any purpose, and a surveillance...
    Torrent Pharma gets shareholder nod to raise up to Rs 5,000 crores

    Torrent Pharma gets shareholder nod to raise up to Rs 5,000 crores

    Medical Dialogues Bureau11 March 2020 3:30 PM IST
    New Delhi: Torrent Pharmaceuticals has said it has received shareholders'' nod to raise up to Rs 5,000 crore through various instruments, including...
    Torrent Pharma Q3 net profit up 2 pc at Rs 251 crore

    Torrent Pharma Q3 net profit up 2 pc at Rs 251 crore

    MD bureau28 Jan 2020 2:25 PM IST
    New Delhi: Drug firm Torrent Pharmaceuticals on Monday reported a 2.03 percent rise in its consolidated net profit to Rs 251 crore for the quarter...
    SEBI exempts Trust from making open offers for Torrent Group Companies

    SEBI exempts Trust from making open offers for Torrent Group Companies

    MD bureau15 Jan 2020 10:00 AM IST
    The trust currently does not hold any shares in these three firms. Pursuant to the scheme of amalgamation, the trust will hold over 71.2 per cent...
    Drug Alert: CDSCO declares 49 drug samples as Not of Standard Quality; Details

    Drug Alert: CDSCO declares 49 drug samples as Not of Standard Quality; Details

    Farhat Nasim14 Jan 2020 2:32 PM IST
    New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) recently flagged 49...
    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details

    Medical Dialogues Bureau15 Nov 2019 4:29 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    NPPA fixes retail price of 14 drug formulations; Details

    NPPA fixes retail price of 14 drug formulations; Details

    Farhat Nasim13 Nov 2019 11:23 AM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma

    Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma

    Medical Dialogues Bureau2 Nov 2019 9:15 AM IST
    Consolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last...
    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Torrent Pharma shares slump 3pc on USFDA warning letter for Gujarat facility

    Medical Dialogues Bureau11 Oct 2019 9:15 AM IST
    Torrent Pharma does not believe that the warning letter will have an impact on the disruption of supplies or the existing revenues from operations of...
    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Dr Reddys suspends worldwide supply of Ranitidine over cancer fears until USFDA probe over

    Medical Dialogues Bureau23 Sept 2019 10:00 AM IST
    Ranitidine is an Over-The-Counter (OTC) and prescription drug which decreases the amount of acid created by the stomach.Hyderabad: Dr Reddy's...
    Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore

    Torrent Pharma Q1 net profit up 33 percent to Rs 216 crore

    Medical Dialogues Bureau24 July 2019 9:30 AM IST
    The firm's India business was up nine per cent year-on-year to Rs 907 crore for the quarter. The US revenues at Rs 376 crore were up by 13 per cent...
    Torrent Pharma, Glenmark enter agreement to market Remogliflozin under trademark Zucator in India

    Torrent Pharma, Glenmark enter agreement to market Remogliflozin under trademark Zucator in India

    Medical Dialogues Bureau11 July 2019 10:00 AM IST
    "Glenmark will manufacture and supply Remogliflozin while Torrent will market the drug under its own trademark 'Zucator' in India," Glenmark Pharma...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok